Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series
Frontiers in Pharmacology · 10.03.2025 · 16
DOI: 10.3389/fphar.2025.1559857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.03.2025. Verfasst von Biyun Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Legionella is a significant pathogen responsible for community-acquired pneumonia and, less commonly, for hospital-acquired pneumonia. Legionella pneumophila , the most prevalent species within the Legionella genus, accounts for 80%–90% of human infections, and often leads to severe pneumonia complicated by multi-organ dysfunction. Omadacycline, a novel tetracycline, has demonstrated in vitro activity against atypical pathogens, including L. pneumophila ; however evidence regarding its application in severe Legionella pneumonia remains limited. In this paper, we report 3 cases of successful treatment of severe Legionella pneumonia with omadacycline in patients who initially did not respond to empirical treatment with moxifloxacin, aiming to provide clinical experience and guidance for the use of omadacycline.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Pharmacy, The Second People's Hospital of Futian District, Shenzhen, China.
- Department of Pharmacy, Shenzhen Nanshan People's Hospital, Shenzhen, China.
Zitieren
APA
Li, B., Liu, L., Li, F., He, C., Chen, Y., Tian, X., Liu, Z., & Zhang, W. (2025). Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1559857
Vancouver
Li B, Liu L, Li F, He C, Chen Y, Tian X, et al. Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1559857
BibTeX
@article{Li2025,
author = {Li, Biyun and Liu, Laiyu and Li, Fei and He, Chunmei and Chen, Yuan and Tian, Xiaodong and Liu, Zhenyu and Zhang, Weizhen},
title = {Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1559857}
}
EUVIMED